{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260915485370/en/Rocket-Pharmaceuticals-Announces-FDA-Alignment-on-Path-to-Complete-Pivotal-Phase-2-Trial-of-RP-A501-in-Danon-Disease", "message": "News view counter 933593 successfully enlarged"}